You are viewing the public part of the archive. Login or request access to view more content.

Displaying 1-5 of 5 results
01:43:46

2012_27

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

2012_27

00:16:51

2008_84_05

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

2008_84_05

00:16:39

2008_82_02

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

2008_82_02

00:48:58

2008_106

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.

2008_106

00:13:58

2006_28_02

XVI International AIDS Conference in Toronto. Panel session on health policy with Swedish AIDS Ambassador Lennart Hjelmåker, UNAIDS Executive Director Peter Piot, Indian Minister of Health Anbunmani Romdass, Sipho Mthathi from TAC and Jeffrey Sturchio from Merck.

2006_28_02